Showing results (171-180 of 197) with videos related to
Sort By:
Pageof 20
Cancer Cell|August 13, 2015
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer TherapyRoberto Ronca, Arianna Giacomini, Emanuela Di Salle, et al.Frontiers in Oncology|April 12, 2019
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell LinesClaudia Fumarola, Nicole Bozza, Riccardo Castelli, et al.Science Advances|October 22, 2021
NAAA-regulated lipid signaling governs the transition from acute to chronic painYannick Fotio, Kwang-Mook Jung, Francesca Palese, et al.Journal of Medicinal Chemistry|June 10, 2020
Design, Synthesis, and Physicochemical and Pharmacological Profiling of 7-Hydroxy-5-oxopyrazolo[4,3-<i>b</i>]pyridine-6-carboxamide Derivatives with Antiosteoarthritic Activity In VivoClaudia Mugnaini, Magdalena Kostrzewa, Marta Bryk, et al.Nature Neuroscience|September 21, 2010
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanismJason R Clapper, Guillermo Moreno-Sanz, Roberto Russo, et al.Biochemical Pharmacology|February 15, 2026
The rare bile acid isoallolithocholic acid (IALCA) is an EphA2 antagonist sparing FXR and TGR5 receptorsAndrea Blesio, Carmine Giorgio, Francesca Romana Ferrari, et al.ACS Chemical Biology|April 16, 2015
A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage ActivationAlison Ribeiro, Silvia Pontis, Luisa Mengatto, et al.European Journal of Medicinal Chemistry|September 14, 2015
Δ(5)-Cholenoyl-amino acids as selective and orally available antagonists of the Eph-ephrin systemRiccardo Castelli, Massimiliano Tognolini, Federica Vacondio, et al.European Journal of Medicinal Chemistry|December 3, 2022
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditionsAlessandro Papa, Silvia Pasquini, Francesca Galvani, et al.Pharmacological Research|July 5, 2024
Discovery of novel FGF trap small molecules endowed with anti-myeloma activitySara Taranto, Riccardo Castelli, Giuseppe Marseglia, et al.Pageof 20